Automated Immunoassay Analyzers Market Size & Share 2023 to 2032
Market Size by Product (Immunofluorescence, Chemiluminescence, ELISA), by Application (Infectious Diseases, Endocrinology, Allergy Testing), by End Use (Hospitals, Diagnostic Laboratories), & Forecast.
Report ID: GMI1727
|
Published Date: May 2023
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Jignesh Rawal
Automated Immunoassay Analyzers Market Size
Automated Immunoassay Analyzers Market size crossed USD 16.9 billion in 2022 and is slated to depict around 14.3% CAGR from 2023 to 2032.
Automated Immunoassay Analyzers Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
Recent trends related to automation and integration of advanced technologies has led to introduction of innovative products in the market. Numerous biotechnology and pharmaceutical companies are increasingly using such products for drug discovery, allergy testing, among various other purposes. Increasing prevalence of infectious diseases, novel product launches, growing range of clinical applications of immunoassay analyzers are other variables that are anticipated to propel the product adoption rate. In addition, such aforementioned factors are set to cumulatively drive the automated immunoassay analyzers industry growth.
An immunoassay analyzer is an advanced tool used in hospitals and laboratories to automate the process of analyzing immunoassays and run biochemical tests to detect the presence and concentration of substances in the given samples. It is a compact, easy to use machine that delivers fast and reliable results.
The automated immunoassay analyzers market is likely to impede tremendous growth due to dearth of qualified and trained professionals in healthcare sector. With the growing elderly population across the world, there is an increasing need for qualified professionals in healthcare facilities such as hospitals, diagnostics, and reference laboratories. Thus, lack of well-trained professionals to maintain the minimum standards of healthcare is predicted to hamper the industry growth.
COVID-19 Impact
The recent outbreak of COVID-19 pandemic had a negative impact on the automated immunoassay analyzers market revenue in 2020. Several restrictions including nation-wide lockdowns were imposed across different countries globally to avoid the spread of the virus. The COVID-19 outbreak had affected the overall healthcare industry including immunoassay analyzers market. Numerous factors including interruption of non-emergent medical services, equipment demand and supply shortages, supply chain disturbances, among other disruptions impacted the market revenue.
As the COVID-19 infection rate decreased the industry witnessed a rapid recovery and an incremental surge in the year-on-year growth trend in the following years. However, the decline in number of patients, propelled the product adoption rate and contributed positively to the market growth.
Automated Immunoassay Analyzers Market Trends
Increasing prevalence of infectious diseases is one of the pivotal factors that is set to drive automated immunoassay analyzers market growth. Early detection of infectious diseases is important to reduce the possibility of severe damage to the body. Thus, accurate and precise screening of infections such as Hepatitis, influenza, STDs, and numerous other infections in minimal time is projected to be a major market growth factor. Furthermore, awareness of diseases has increased the disease diagnosis in early stages for preventing complications by undergoing diagnostic tests.
Automated Immunoassay Analyzers Market Analysis
The chemiluminescence immunoassay analyzer segment of automated immunoassay analyzers market exceeded USD 5.3 billion in 2022. The largest share is attributed to increasing use owing to high accuracy and sensitivity of the diagnosis using low analyte concentration. These immunoassay analyzers improve the work competence by identification of more than hundreds of analytes per hour. The higher receptiveness and reliability of chemiluminescence immunoassay will drive customer preference for these products. Thus, the above-mentioned parameters are likely to boost the segmental progression.
Based on application, the infectious diseases segment dominated the automated immunoassay analyzers market in terms of revenue and was valued at USD 5.0 billion in 2022. Infectious diseases are caused by pathogenic microorganisms such as parasites, bacteria and viruses and are highly communicable. Intensifying adoption of advanced molecular techniques coupled with increasing government and non-profit organization’s intervention aiming to reduce the burden of infectious diseases especially in underdeveloped and developing regions will drive the industry growth.
The hospitals segment is anticipated to witness 14.7% CAGR through 2032. Rise in target population of people suffering from heart and lungs related disorders, increasing awareness level, facilitative reimbursement schemes and availability of better care facilities among others are prime factors responsible for increasing patient footfall in hospital settings. Additionally, presence of well-trained and equipped healthcare personnel, availability of better infrastructure and advanced equipment for improved diagnostic testing such as cardiac marker testing, along with supportive government schemes focusing on reducing the heart related disease burden will further fuel the segmental growth. Moreover, owing to afore-mentioned pointers, the market is observing robust growth.
North America automated immunoassay analyzers market and is expected to reach over USD 23.2 billion by 2032. Increasing prevalence of infectious diseases, different allergies, and cancer will contribute to the rising demand for automated immunoassay analyzers for accurate and early diagnosis across North America over the forecast period. Favorable demographic trends including presence of significant patient pool, rise in geriatric population, increasing awareness and average life expectancy will render significant positive impact.
Automated Immunoassay Analyzers Market Share
Few of the leading players operating in the automated immunoassay analyzers market include
The market is consolidated in nature, with leading players, regional and local companies, along with start-ups further consolidating the industry competition. The leading market players are involved in strategic developments including research and development, novel product launches, partnerships, to improve their market positioning and revenue generating capabilities.
Automated Immunoassay Analyzers Industry News:
This automated immunoassay analyzers market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in (USD million) and volume (Units) from 2018 to 2032, for the following segments:
Click here to Buy Section of this Report
By Product
By Application
By End-use
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →